We are live on ! Find out more
JGGDR

JGP Global Gestao de Recursos Portfolio holdings

AUM $45.3M
1-Year Est. Return 42.75%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+42.75%
3 Year Est. Return
+205.51%
5 Year Est. Return
+441.7%
10 Year Est. Return
+707.39%
AUM
$26.6M
AUM Growth
-$156M
Cap. Flow
-$158M
Cap. Flow %
-595.57%
Top 10 Hldgs %
47.03%
Holding
70
New
9
Increased
9
Reduced
27
Closed
25

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.81M
2
AAPL icon
Apple
AAPL
+$722K
3
RUN icon
Sunrun
RUN
+$258K
4
MOH icon
Molina Healthcare
MOH
+$224K
5
TFX icon
Teleflex
TFX
+$209K

Sector Composition

Rank Sector Weight
1 Healthcare 84.97%
2 Technology 11.11%
3 Consumer Staples 0%
4 Communication Services 0%
5 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$3.35T
$1.87M 7.03%
+8,407
New +$1.81M
UNH icon
2
UnitedHealth
UNH
$383B
$1.56M 5.87%
4,454
+42
+1% +$14.1K
ISRG icon
3
Intuitive Surgical
ISRG
$126B
$1.56M 5.87%
5,721
-204
-3% -$50.7K
ONC
4
BeOne Medicines Ltd
ONC
$33.4B
$1.47M 5.51%
5,672
+25
+0.4% +$6.88K
TMO icon
5
Thermo Fisher Scientific
TMO
$214B
$1.25M 4.69%
2,679
-36
-1% -$16.9K
IBB icon
6
iShares Biotechnology ETF
IBB
$9.52B
$1.04M 3.92%
6,887
-3,113
-31% -$445K
VRTX icon
7
Vertex Pharmaceuticals
VRTX
$122B
$1.03M 3.87%
4,360
-156
-3% -$35.8K
ALXN
8
DELISTED
Alexion Pharmaceuticals
ALXN
$1M 3.76%
6,409
-4
-0.1% -$514
BDX icon
9
Becton Dickinson
BDX
$45.6B
$932K 3.5%
3,818
-162
-4% -$37.8K
AAPL icon
10
Apple
AAPL
$4.9T
$796K 2.99%
+6,000
New +$722K
DHR icon
11
Danaher
DHR
$138B
$745K 2.8%
3,783
-39
-1% -$7.82K
SYK icon
12
Stryker
SYK
$133B
$734K 2.76%
2,996
-54
-2% -$12.2K
KOD icon
13
Kodiak Sciences
KOD
$2.66B
$619K 2.33%
4,213
+229
+6% +$25.5K
ASND icon
14
Ascendis Pharma A/S
ASND
$16.5B
$587K 2.21%
3,519
-65
-2% -$10.7K
A icon
15
Agilent Technologies
A
$39.2B
$549K 2.06%
4,636
-99
-2% -$11K
ARGX icon
16
argenx
ARGX
$54.6B
$547K 2.06%
1,859
-1
-0.1% -$275
MRTX
17
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$523K 1.97%
2,380
-16
-0.7% -$3.46K
AMGN icon
18
Amgen
AMGN
$209B
$519K 1.95%
2,259
-35
-2% -$8.07K
HCA icon
19
HCA Healthcare
HCA
$85.7B
$504K 1.9%
3,064
-117
-4% -$17.1K
ABBV icon
20
AbbVie
ABBV
$455B
$497K 1.87%
4,634
-72
-2% -$6.92K
CI icon
21
Cigna
CI
$76.1B
$463K 1.74%
2,223
-1
-0% -$196
EXAS
22
DELISTED
Exact Sciences
EXAS
$462K 1.74%
3,487
+114
+3% +$13.8K
BMRN icon
23
BioMarin Pharmaceuticals
BMRN
$11.7B
$449K 1.69%
5,118
-166
-3% -$13.2K
REGN icon
24
Regeneron Pharmaceuticals
REGN
$77.4B
$431K 1.62%
892
-3
-0.3% -$1.62K
CNC icon
25
Centene
CNC
$30.1B
$425K 1.6%
7,088
+86
+1% +$5.46K

Similar funds

JGP Global Gestao de Recursos's Q4 2020 Portfolio in Review

As of Q4 2020, JGP Global Gestao de Recursos held 70 positions worth $26.6M, down 85% from $183M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

JGP Global Gestao de Recursos withdrew a net $158M in Q4 2020, closing 25 positions and reducing 27 holdings. Its most notable exit was Mercado Libre, an estimated $39.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, JGP Global Gestao de Recursos opened a new position in Microsoft worth $1.87M.

  • JGP Global Gestao de Recursos's largest Q4 2020 buy was Microsoft: 8,407 shares worth $1.87M.
  • JGP Global Gestao de Recursos added most to Merck in Q4 2020, an estimated $62.3K increase.
  • JGP Global Gestao de Recursos's biggest Q4 2020 reduction was iShares Biotechnology ETF, cutting an estimated $445K.
  • JGP Global Gestao de Recursos fully exited Mercado Libre in Q4 2020, selling an estimated $39.9M.
  • JGP Global Gestao de Recursos's ten largest holdings make up 47% of its $26.6M portfolio in Q4 2020.
  • JGP Global Gestao de Recursos opened 9 new positions and closed 25 in Q4 2020.
  • JGP Global Gestao de Recursos's portfolio value fell 85% quarter-over-quarter to $26.6M.

Based on JGP Global Gestao de Recursos's 13F filing for Q4 2020, filed 27 Jan 2021.